Brief: Carerx Reports 25% Year-Over-Year Growth In Revenue And 54% Year-Over-Year Growth In Adjusted EBITDA For Second Quarter Of 2021
Aug 9 (Reuters) - CareRx Corp CRRX.TO :
* CARERX REPORTS 25% YEAR-OVER-YEAR GROWTH IN REVENUE AND
54%
YEAR-OVER-YEAR GROWTH IN ADJUSTED EBITDA FOR SECOND QUARTER OF
2021
* CARERX CORP - QTRLY LOSS PER SHARE $0.28
Source text for Eikon: ID:nCNWgHdYZa
Further company coverage: CRRX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CareRx
See all newsCanada's CareRx Q1 revenue and adjusted EBITDA rise
Canada's CareRx quarterly revenue slightly beats estimates on beds serviced growth
Long-term care pharmacy CareRx Q3 revenue misses analyst expectations
Canada's CareRx Q2 revenue in-line with estimates
Brief: CareRx Reports Results For The Third Quarter Of 2024